Arkolith/Insider Trading/LAB/Form 4

Egholm Michael

President & CEO, DirectorSTANDARD BIOTOOLS INC. (LAB) · full profile →Form 4 · filed Apr 8, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)197K—$06.8M
Apr 6, 2026Tax withholding(F)95K$0.91$86K6.7M
Mar 20, 2026Grant(A)1.0M—$06.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)197K—$00
Mar 20, 2026Grant(A)2.3M—$02.3M

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-148615) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML